Information Library

Results for: Clinical Services - Clinical Monitoring - Asia - Australia and New Zealand

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Model-Based Drug Development

    Brochure — October 4, 2011
    Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns.

  • Polish Pharmaceutical and Healthcare Sector

    Media Coverage — September 9, 2011
    To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research

  • Parkinson's Disease - Ambitious Recruitment

    Case Study — February 1, 2011
    Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease.

  • A Lock on Consistency

    Case Study — February 1, 2011
    A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction.

  • Acute Coronary Syndrome - Tailored Solutions

    Case Study — February 1, 2011
    Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.

  • MediGuard

    Presentation — November 2, 2010
    MediGuard presentation at AusBiotech 2010

  • On-Time Results

    Case Study — September 14, 2010
    The commitment of the Quintiles team to the delivery of the study on time despite significant problems outside our control proved decisive in this global trial.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences